MLICM
BEAM icon

Metropolitan Life Insurance Company (MetLife)’s Beam Therapeutics BEAM Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,847
Closed -$127K – 265
2024
Q1 		$127K Sell
3,847
-370
-9% -$11.5K 0.01% 924
2023
Q4 		$115K Hold
4,217
– – 0.01% 1005
2023
Q3 		$101K Buy
4,217
+483
+13% +$12.9K 0.01% 1004
2023
Q2 		$119K Buy
3,734
+208
+6% +$6.75K 0.01% 928
2023
Q1 		$108K Sell
3,526
-402
-10% -$15.9K 0.01% 962
2022
Q4 		$154K Buy
3,928
+92
+2% +$4.12K 0.01% 834
2022
Q3 		$183K Hold
3,836
– – 0.01% 707
2022
Q2 		$148K Buy
3,836
+572
+18% +$22.7K 0.01% 851
2022
Q1 		$187K Sell
3,264
-9,829
-75% -$645K 0.01% 848
2021
Q4 		$1.04M Hold
13,093
– – 0.01% 930
2021
Q3 		$1.14M Buy
13,093
+228
+2% +$22.9K 0.02% 855
2021
Q2 		$1.66M Buy
12,865
+2,028
+19% +$162K 0.02% 640
2021
Q1 		$867K Sell
10,837
-422
-4% -$40.1K 0.01% 1058
2020
Q4 		$919K Buy
11,259
+705
+7% +$34.7K 0.01% 936
2020
Q3 		$260K Buy
10,554
+5,872
+125% +$146K ﹤0.01% 1618
2020
Q2 		$131K Hold
4,682
– – ﹤0.01% 2092
2020
Q1 		$84.3K Buy
+4,682
New +$102K ﹤0.01% 2136

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s BEAM Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Beam Therapeutics (BEAM) in Q2 2024, closing a stake of 3,847 shares — an estimated $127K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in BEAM in Q1 2020 and held it in 17 quarters. The position peaked at $1.66M in Q2 2021. 214 funds tracked by Wall St. Rank hold BEAM as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Beam Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,847 Beam Therapeutics shares in Q2 2024, an estimated $127K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Beam Therapeutics in Q1 2020 and held it in 17 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Beam Therapeutics position peaked at $1.66M in Q2 2021.
  • 214 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.